Cargando…

Review of Pharmacokinetics and Pharmacogenetics in Atypical Long-Acting Injectable Antipsychotics

Over the last two decades, pharmacogenetics and pharmacokinetics have been increasingly used in clinical practice in Psychiatry due to the high variability regarding response and side effects of antipsychotic drugs. Specifically, long-acting injectable (LAI) antipsychotics have different pharmacokin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toja-Camba, Francisco José, Gesto-Antelo, Nerea, Maroñas, Olalla, Echarri Arrieta, Eduardo, Zarra-Ferro, Irene, González-Barcia, Miguel, Bandín-Vilar, Enrique, Mangas Sanjuan, Victor, Facal, Fernando, Arrojo Romero, Manuel, Carracedo, Angel, Mondelo-García, Cristina, Fernández-Ferreiro, Anxo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308912/ https://www.ncbi.nlm.nih.gov/pubmed/34201784 http://dx.doi.org/10.3390/pharmaceutics13070935

Ejemplares similares

A Review of Population Pharmacokinetic Analyses of Linezolid
por: Bandín-Vilar, Enrique, et al.
Publicado: (2022)

Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration
por: García-Quintanilla, Laura, et al.
Publicado: (2019)

Ampicillin Stability in a Portable Elastomeric Infusion Pump: A Step Forward in Outpatient Parenteral Antimicrobial Therapy
por: Rodríguez-Martínez, Lorena, et al.
Publicado: (2023)

Deletion of the CYP2D6 gene as a likely explanation for the serious side effects of the antipsychotic drug pimozide: a case report
por: Facal, Fernando, et al.
Publicado: (2023)

Recent Advances in Proteomics-Based Approaches to Studying Age-Related Macular Degeneration: A Systematic Review
por: García-Quintanilla, Laura, et al.
Publicado: (2022)

Enhancing Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Comparative Analysis of Rapid Point-of-Care Infliximab, Adalimumab and Anti-Drug Antibodies’ Determination against ELISA
por: Toja-Camba, Francisco José, et al.
Publicado: (2023)

Ocular Biodistribution Studies Using Molecular Imaging
por: Castro-Balado, Ana, et al.
Publicado: (2019)

Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence
por: Castro-Balado, Ana, et al.
Publicado: (2022)

Pharmacogenetics and outcome with antipsychotic drugs
por: Pouget, Jennie G., et al.
Publicado: (2014)

Pharmacogenetics of antipsychotic-induced side effects
por: Lencz, Todd, et al.
Publicado: (2009)

The Pharmacogenetics of Symptom Response to Antipsychotic Drugs
por: Reynolds, Gavin P
Publicado: (2012)

EXPERIENCE OF PHARMACOGENETIC TESTING IN THE TREATMENT OF ANTIPSYCHOTICS
por: Kaydan, M., et al.
Publicado: (2023)

Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration
por: García-Quintanilla, Laura, et al.
Publicado: (2023)

Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence
por: Castro-Balado, Ana, et al.
Publicado: (2023)

Pharmacogenetic tests for antipsychotic medications: clinical implications and considerations
por: Eum, Seenae, et al.
Publicado: (2016)

Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics
por: Boloc, Daniel, et al.
Publicado: (2018)

Recent Research in Ocular Cystinosis: Drug Delivery Systems, Cysteamine Detection Methods and Future Perspectives
por: Castro-Balado, Ana, et al.
Publicado: (2020)

A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments
por: Arranz, Maria J., et al.
Publicado: (2019)

Perspectives of Therapeutic Drug Monitoring of Biological Agents in Non-Infectious Uveitis Treatment: A Review
por: Busto-Iglesias, Manuel, et al.
Publicado: (2023)

The Road so Far in Colorectal Cancer Pharmacogenomics: Are We Closer to Individualised Treatment?
por: Simões, Ana Rita, et al.
Publicado: (2020)

Pharmacogenetics of antipsychotic therapy: pivotal research issues and the prospects for clinical implementation
por: Lerer, Bernard, et al.
Publicado: (2006)

Author Correction: Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics
por: Boloc, Daniel, et al.
Publicado: (2019)

Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
por: Płaza, Olga, et al.
Publicado: (2022)

Efficacy and Safety of Inhaled Ethanol in Early-Stage SARS-CoV-2 Infection in Older Adults: A Phase II Randomized Clinical Trial
por: Castro-Balado, Ana, et al.
Publicado: (2023)

Pharmacogenetics of antipsychotic adverse effects: Case studies and a literature review for clinicians
por: Foster, Adriana, et al.
Publicado: (2007)

Pharmacogenetic Aspects of Antipsychotic Drug-induced Weight Gain - A Critical Review
por: Reynolds, Gavin P.
Publicado: (2012)

Pharmacogenetic markers to predict safety of antipsychotics in adolescents experiencing acute psychotic episodes
por: Ivashchenko, D., et al.
Publicado: (2022)

Microbiome in Immune-Mediated Uveitis
por: Rodríguez-Fernández, Carmen Antía, et al.
Publicado: (2022)

Anti-Inflammatory Effect of Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drops in an Endotoxin-Induced Uveitis Model
por: García-Otero, Xurxo, et al.
Publicado: (2021)

Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop
por: García-Otero, Xurxo, et al.
Publicado: (2021)

The pharmacogenetics of the new-generation antipsychotics – A scoping review focused on patients with severe psychiatric disorders
por: Vasiliu, Octavian
Publicado: (2023)

Pharmacogenetics of Antipsychotic-Induced Movement Disorders as a Resource for Better Understanding Parkinson’s Disease Modifier Genes
por: Greenbaum, Lior, et al.
Publicado: (2015)

Man-In-The-Barrel. A Case of Cervical Spinal Cord Infarction and Review of the Literature
por: Antelo, María José García, et al.
Publicado: (2013)

Antipsychotic Drugs Opposite to Metabolic Risk: Neurotransmitters, Neurohormonal and Pharmacogenetic Mechanisms Underlying with Weight Gain and Metabolic Syndrome
por: Milano, Walter, et al.
Publicado: (2013)

Pharmacogenetic testing in schizophrenia in real clinical practice: before or after antipsychotic -induced adverse drug reactions development?
por: Abdyrakhmanova, A., et al.
Publicado: (2022)

A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia
por: Osmanova, Diana Z., et al.
Publicado: (2019)

Development and Characterization of Inhaled Ethanol as a Novel Pharmacological Strategy Currently Evaluated in a Phase II Clinical Trial for Early-Stage SARS-CoV-2 Infection
por: Castro-Balado, Ana, et al.
Publicado: (2021)

Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study
por: Scherf-Clavel, Maike, et al.
Publicado: (2023)

Cancer pharmacogenetics
por: Marsh, S, et al.
Publicado: (2004)

Experimental Pharmacogenetics
por: Lubs, Herbert A.
Publicado: (1964)

Cannot write session to /tmp/vufind_sessions/sess_qdk04hha07pl806mb3edqut6d1